Association of glycated hemoglobin levels with 3-year mortality in hospitalized older adults with diabetes: The role of frailty

doi:10.12998/wjcc.v14.i14.120574

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 14

This Article

(36)

(26)

(0)

(1)

(548)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Clin Cases. May 16, 2026; 14(14): 120574
Published online May 16, 2026. doi: 10.12998/wjcc.v14.i14.120574

Table 2 Distribution of antidiabetic treatment according to glycated hemoglobin categories in the total study sample, n (%)

Variable	Total population, n = 430	HbA1c < 6.5%, n = 246	HbA1c 6.5%-8.0%, n = 137	HbA1c > 8.0%, n = 47	P value
Metformin	258 (60.0)	144 (58.5)	86 (62.8)	28 (59.6)	0.718
Sulfonylureas	81 (18.8)	45 (18.3)	25 (18.2)	11 (23.4)	0.698
DPP4-i	188 (43.7)	105 (42.7)	54 (39.4)	29 (61.7)	0.026
SGLT2i	25 (5.8)	13 (5.3)	11 (8.0)	1 (2.1)	0.284
GLP-1 agonists	10 (2.3)	5 (2.0)	5 (3.6)	0 (0.0)	0.322
Basal insulin	129 (30.0)	81 (32.9)	38 (27.7)	10 (21.3)	0.219
Rapid insulin	54 (12.6)	33 (13.4)	15 (10.9)	6 (12.8)	0.783

DPP4-i: Dipeptidyl peptidase-4 inhibitor; SGLT2i: Sodium glucose co-transporter 2 inhibitors; GLP-1: Glucagon like peptide; HbA1c: Glycated hemoglobin.

Full Size Table

Citation: Papakitsou I, Papazachariou A, Filippatos TD. Association of glycated hemoglobin levels with 3-year mortality in hospitalized older adults with diabetes: The role of frailty. World J Clin Cases 2026; 14(14): 120574
URL: https://www.wjgnet.com/2307-8960/full/v14/i14/120574.htm
DOI: https://dx.doi.org/10.12998/wjcc.v14.i14.120574

Papakitsou I, Papazachariou A, Filippatos TD. Association of glycated hemoglobin levels with 3-year mortality in hospitalized older adults with diabetes: The role of frailty. World J Clin Cases 2026; 14(14): 120574 [DOI: 10.12998/wjcc.v14.i14.120574]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.